285 related articles for article (PubMed ID: 21305359)
1. Treatment of primary aldosteronism: Where are we now?
Karagiannis A
Rev Endocr Metab Disord; 2011 Mar; 12(1):15-20. PubMed ID: 21305359
[TBL] [Abstract][Full Text] [Related]
2. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
Fourkiotis V; Vonend O; Diederich S; Fischer E; Lang K; Endres S; Beuschlein F; Willenberg HS; Rump LC; Allolio B; Reincke M; Quinkler M;
Eur J Endocrinol; 2013 Jan; 168(1):75-81. PubMed ID: 23033260
[TBL] [Abstract][Full Text] [Related]
5. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism.
Pechère-Bertschi A; Herpin D; Lefebvre H
Ann Endocrinol (Paris); 2016 Jul; 77(3):226-34. PubMed ID: 27315759
[TBL] [Abstract][Full Text] [Related]
6. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
Riester A; Reincke M
Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
[TBL] [Abstract][Full Text] [Related]
7. Primary aldosteronism, diagnosis and treatment in Japan.
Takeda Y; Karashima S; Yoneda T
Rev Endocr Metab Disord; 2011 Mar; 12(1):21-5. PubMed ID: 21424323
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era.
Catena C; Colussi G; Sechi LA
Eur J Endocrinol; 2013 Jan; 168(1):C1-5. PubMed ID: 23082005
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of surgery and outcomes in patients with primary aldosteronism.
Muth A; Ragnarsson O; Johannsson G; Wängberg B
Br J Surg; 2015 Mar; 102(4):307-17. PubMed ID: 25605481
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Unilateral PA by Adrenalectomy: Potential Reasons for Incomplete Biochemical Cure.
Yang Y; Reincke M; Williams TA
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):100-108. PubMed ID: 30130807
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J
J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707
[TBL] [Abstract][Full Text] [Related]
14. Primary aldosteronism: Practical recommendations for treatment and follow-up.
Araujo-Castro M; Pascual-Corrales E; Martín Rojas P; Parra Ramírez P
Hipertens Riesgo Vasc; 2023; 40(4):215-221. PubMed ID: 37993292
[TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism in pregnancy.
Forestiero V; Sconfienza E; Mulatero P; Monticone S
Rev Endocr Metab Disord; 2023 Feb; 24(1):39-48. PubMed ID: 35536535
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary hyperaldosteronism.
Araujo-Castro M
Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
Wachtel H; Fraker DL
Curr Cardiol Rep; 2021 Jun; 23(7):89. PubMed ID: 34081226
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Amar L; Plouin PF; Steichen O
Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
[TBL] [Abstract][Full Text] [Related]
19. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism.
Maule S; Bertello C; Rabbia F; Milan A; Mulatero P; Milazzo V; Papotti G; Veglio F
Hypertens Res; 2011 Oct; 34(10):1078-81. PubMed ID: 21677661
[TBL] [Abstract][Full Text] [Related]
20. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
